Vodafone’s Global IoT Technology Makes Mobile Diabetes Management Accessible for Smart Meter’s iGlucose® Platform
June 20 2017 - 9:00AM
Vodafone today announced that it is working with Smart Meter LLC.,
a mobile health (mHealth) services provider for diabetes
management, to bring reliable and efficient accessibility to its
customers around the world. Smart Meter’s iGlucose platform will
benefit from Vodafone’s global Internet of Things (IoT) network to
address customer demand in more than 160 countries.
The iGlucose blood glucose meter wirelessly sends blood glucose
readings and other information to a personal web portal via
Vodafone’s global IoT network. In the web portal, the person with
diabetes and their designated Circle of Care can access customized
trend reports and digital logbooks that are automatically updated
every time the person with diabetes tests.
The number of people impacted by diabetes continues to rise.
According to the International Diabetes Foundation, the total
number of people with diabetes is projected to rise from 415
million in 2015 to 642 million in 2040. Many published
studies have proven the impact of mHealth solutions on lowering the
glycated hemoglobin (HbA1C) of people with diabetes. However,
many of these existing options are not affordable or easy to
use. Smart Meter’s iGlucose® platform which aims to improve
the management of diabetes lacking in the current mHealth
marketplace, has recently received FDA clearance and it’s CE
Mark.
“Managing diabetes is a 24-hour, 7-day-a-week job, and often
requires the support of a Circle of Care consisting of healthcare
providers, payers and loved ones,” said Smart Meter CEO Cliff
McIntosh. “The reliable and instantaneous two-way
communication we can provide through an affordable platform is a
real game-changer for people that are managing diabetes – they know
they always have the support of others when needed. Vodafone
listened to our needs, provided a customized solution to fit our
requirements, and offered the expertise and ability to give us
seamless global accessibility, all making our decision to partner
with Vodafone an easy one.”
The iGlucose platform provides personalized accessibility
between people with diabetes and their Circle of Care by
automatically sending glucose readings via text message or email to
family members or other designees. Supportive messages, tips and
reminders of when to test are also part of the service.
Anyone in the Circle of Care can send customized messages back to
individuals to address an immediate issue or offer
encouragement.
Vodafone Group’s Director of IoT Ivo Rook said, “Connected
technologies are transforming healthcare, from providing better
care to improving research and development. One area that I believe
is ideally placed to benefit from this kind of technology is
helping patients to fully commit to their treatment plans.”
With iGlucose’s population management, healthcare providers can
access patient data in real time via a web portal. Digital triage
can be performed to see which patients are low, out of control or
not testing. Focus can be given to the patients needing the most
attention first. Text and e-mail encouragement can be given to
those improving their bG testing trends. Multiple studies have
shown that when the number of these touch points between the
caregiver and the person with diabetes are increased, therapy
compliance and drug adherence improve. In addition, the
iGlucose meter meets ISO 2013 standards and data collected can be
used for Medicare Part B audits, lowering the time needed for
payers to collect the data and reduce their overall costs.
Vodafone’s global network and the Vodafone Global IoT SIM means
Smart Meter can provide these services around the world with
confidence without being distracted with the task of
country-by-country IT integration.
About Smart Meter LLCSmart Meter, LLC. is a
medical device company and mHealth solutions provider focused on
bringing reliable and efficient device connectivity to their
customers around the world. Its iGlucose blood glucose
monitor is an affordable, state-of-the-art blood glucose meter with
built-in GSM connectivity allowing people with diabetes to create a
customizable network of care via a personal web portal. The
iGlucose platform provides a new level of connectivity for the
patient, the health care professional and the payer resulting in
better diabetes management while saving time and money.
www.smartmetercorporation.com
About Vodafone Group Vodafone Group is one of
the world’s largest telecommunications companies and provides a
range of services including voice, messaging, data and fixed
communications. Vodafone Group has mobile operations in 26
countries, partners with mobile networks in 49 more, and fixed
broadband operations in 17 markets. As of 31 March 2017, Vodafone
Group had 515.7 million mobile customers and 17.9 million fixed
broadband customers, including India and all of the customers in
Vodafone’s joint ventures and associates. For more information,
please visit: www.vodafone.com.
Media Contact:
Melissa Salottolo, Vodafone Americas
917-836-4429
melissa.salottolo@vodafone.com
Jeff Christensen, SignalWest Public Relations, LLC
831-566-0275
Jeff@SignalWestPR.com
Vodafone (NASDAQ:VOD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vodafone (NASDAQ:VOD)
Historical Stock Chart
From Sep 2023 to Sep 2024